Mauna Kea Technologies SA
Company Profile
- Business description- Mauna Kea Technologies SA is a medical device company that develops, manufactures and markets an imaging platform for visualizing tissue at the cellular level, in real time, during standard procedures, with the mission of eliminating uncertainties in diagnosis and treatment through direct visualization of tissue in vivo at the microscopic level. The company’s flagship product, Cellvizio, is the smallest microscope, designed for direct use during minimally invasive procedures. It operates in a single business segment: endomicroscopy. Its geographical presence includes EMEA (Europe, Middle East, Africa), USA and Canada, and Asia with the majority of the revenue deriving from USA and Canada. 
- Contact- 9 rue d'Enghien 
 Paris75010
 FRA- T: +33 148240345 
- Sector- Healthcare - Stock type- Defensive 
- Industry- Medical Devices - Fiscal Year End- 31 December 2025 - Employees- 53 
Stocks News & Analysis
stocks
Microsoft earnings: Strong, including Azure, but overall guidance is in line
stocks
After earnings, is Tesla stock a buy, a sell, or fairly valued?
Morningstar Investment Ideas
Markets
| Index | Last price | Change | % Change | 
|---|---|---|---|
| All Ordinaries | 9,178.00 | 28.70 | -0.31% | 
| CAC 40 | 8,108.76 | 92.12 | -1.12% | 
| DAX 40 | 23,949.74 | 169.15 | -0.70% | 
| Dow JONES (US) | 47,510.71 | 11.41 | -0.02% | 
| FTSE 100 | 9,707.37 | 52.69 | -0.54% | 
| HKSE | 25,906.65 | 376.04 | -1.43% | 
| NASDAQ | 23,754.41 | 173.26 | 0.73% | 
| Nikkei 225 | 52,411.34 | 1,085.73 | 2.12% | 
| NZX 50 Index | 13,548.32 | 89.03 | 0.66% | 
| S&P 500 | 6,842.07 | 19.73 | 0.29% | 
| S&P/ASX 200 | 8,881.90 | 31.30 | -0.35% | 
| SSE Composite Index | 3,954.79 | 32.11 | -0.81% |